News Conference News ACC 2024 EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2 Shelley Wood April 07, 2024
News Conference News ACC 2023 Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin Yael L. Maxwell March 13, 2023
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News ACC 2022 Bentracimab Swiftly Reverses Ticagrelor, Platelet-Function Study Affirms Todd Neale April 02, 2022
News Conference News ACC 2019 Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE Caitlin E. Cox March 25, 2019
News Conference News ACC 2018 Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role Yael L. Maxwell March 11, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Conference News ACC 2018 iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis Caitlin E. Cox March 10, 2018
News Conference News ACC 2017 CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS Yael L. Maxwell March 18, 2017
News Conference News ACC 2012 Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel Jason Kahn March 24, 2012